Association of active immunotherapy with outcomes in cancer patients with COVID-19: a systematic review and meta-analysis
Figure 3.Forest plot of the multivariate analysis for the association between active immunotherapy and mortality. Adjusted variables for the study by Lee 2020 [22]: age, sex, and presence of comorbidities; adjusted variables for the study by Mehta 2021 [24]: age and presence of comorbidities; and adjusted variables for the study by Yarza 2020 [35]: age, sex, Eastern Cooperative Oncology Group score (ECOG), presence of metastasis, previous venous thromboembolic event (VTE), and presence of chronic obstructive pulmonary disease (COPD). CI, confidence interval; IV, inverse variance; SE, standard error.